Close menu

 

 

 

Mr. Jacon will be joining MagIA diagnostics’ board after a long career in the in-vitro diagnostics business. In his previous roles, Philippe JACON was the Executive Vice President, Emerging Markets, SVP Global Access at CEPHEID from 2013 to 2023. Previously, he was CEO of the Foundation of Innovative New Diagnostics (FIND), General Director of the European Diagnostics Manufacturers Association and Worldwide President of Becton Dickinson Diagnostics Systems. Philippe JACON sat on the board of MedTech Europe between 2013 and 2022.

 

Read the press release

 

 

More information